Wolverine Asset Management’s Translational Development Acquisition Corp TDAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.2M Sell
1,251,356
-115,759
-8% -$1.22M 0.13% 164
2025
Q4
$14.3M Sell
1,367,115
-190,019
-12% -$1.98M 0.11% 188
2025
Q3
$16.1M Buy
1,557,134
+202,443
+15% +$2.09M 0.12% 172
2025
Q2
$14M Buy
1,354,691
+587,606
+77% +$5.97M 0.13% 179
2025
Q1
$7.73M Buy
+767,085
New +$7.71M 0.09% 230

Other funds holding TDAC

Wolverine Asset Management's TDAC Position: Q1 2026 in Review

Wolverine Asset Management reduced its Translational Development Acquisition Corp (TDAC) stake by 8.5% in Q1 2026, selling an estimated $1.22M and leaving 1,251,356 shares worth $13.2M. The position accounts for 0.13% of the portfolio, ranked #164.

Wolverine Asset Management first reported a position in TDAC in Q1 2025 and has held it in 5 quarters since. The position peaked at $16.1M in Q3 2025. 48 funds tracked by Wall St. Rank hold TDAC as of Q1 2026.

  • Wolverine Asset Management held 1,251,356 shares of Translational Development Acquisition Corp worth $13.2M as of Q1 2026.
  • Wolverine Asset Management sold 115,759 Translational Development Acquisition Corp shares in Q1 2026, an estimated $1.22M.
  • Translational Development Acquisition Corp made up 0.13% of Wolverine Asset Management's portfolio in Q1 2026, its #164 holding.
  • Wolverine Asset Management first reported a position in Translational Development Acquisition Corp in Q1 2025 and has held it in 5 quarters since.
  • Wolverine Asset Management's Translational Development Acquisition Corp position peaked at $16.1M in Q3 2025.
  • 48 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q1 2026.

Based on Wolverine Asset Management's 13F filing for Q1 2026, filed 4 May 2026.